Effectiveness and safety of emergency department-based streaming interventions for low-acuity utilizers - systematic review and meta-analysis
Abstract
BACKGROUND: Emergency department (ED) crowding is a global challenge, presumably aggravated by low-acuity utilization. Various patient streaming interventions have been implemented in EDs to reduce potentially unnecessary utilization and improve care coordination and patient throughput. This systematic review examined the effectiveness and safety of ED-based streaming for low-acuity patients. METHODS: A search of MEDLINE, EMBASE, CINAHL, and Cochrane Library databases was conducted up to December 2, 2025. Screening and data extraction were performed in duplicate. RCTs, non-randomized controlled trials, interrupted time series, and before-after studies on general practitioner (GP) streaming, ED streaming, and urgent care (UC) streaming for low-acuity utilizers were eligible. We assessed outcomes related to care effectiveness, patient safety, and cost-effectiveness. Random-effects meta-analyses were performed. Risk of bias was assessed by the Effective Public Health Practice Project tool. RESULTS: We included 137 publications reporting on 119 research projects. Meta-analyses showed higher proportions of cases managed in alternative tracks for GP streaming (0.32; CI 0.17;0.51) compared to ED streaming (0.25; CI 0.15;0.37). Both GP and ED streaming demonstrated reductions in length of stay, particularly for low-acuity patients (GP: SMD − 0.85; CI -1.37;-0.33; ED: SMD − 0.39; CI -0.56;-0.22). Safety outcomes, including leaving without being seen and unplanned ED reattendances,…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.